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Abstract
The study of functional RNAs of various sizes and structures requires efficient methods for their synthesis and purification.
Here, 23 group I intron variants ranging in length from 246 to 341 nucleotides—some containing exons—were subjected to
a native purification technique previously applied only to shorter RNAs (,160 nucleotides). For the RNAs containing both
exons, we adjusted the original purification protocol to allow for purification of radiolabeled molecules. The resulting RNAs
were used in folding assays on native gel electrophoresis and in self-splicing assays. The intron-only RNAs were subjected to
the regular native purification scheme, assayed for folding and employed in crystallization screens. All RNAs that contained
a3 9 overhang of one nucleotide were efficiently cleaved off from the support and were at least 90% pure after the non-
denaturing purification. A representative subset of these RNAs was shown to be folded and self-splicing after purification.
Additionally, crystals were grown for a 286 nucleotide long variant of the Clostridium botulinum intron. These results
demonstrate the suitability of the native affinity purification method for the preparation of group I introns. We hope these
findings will stimulate a broader application of this strategy to the preparation of other large RNA molecules.
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Introduction
The rapid increase in the discovery of RNA molecules as key
players in biological mechanisms [1,2] requires fast and efficient
methods to prepare natively folded molecules suitable for
biochemical analyses of their structures and functions. Such a
method has been developed that employs non-denaturing affinity
separation mediated by a tag engineered on the 39 end of the RNA
of interest [3]. This additional sequence comprised a mutant of the
genomic hepatitis delta virus (HDV) ribozyme that self-cleaves
only in the presence of imidazole [4], followed by two stem-loops
derived from the signal recognition particle (SRP) RNA [5]. After
transcription completion, the RNA was separated from the
reaction through binding of the dual SRP tag to its protein
partner (a domain of the T. maritima Ffh protein (TmaM))
immobilized on a resin, and then recovered by elution in the
presence of imidazole (Figure 1A). This technique facilitated the
crystallization of several small- and medium-size RNAs (,160
nucleotides (nt)), in particular the purine- and the magnesium-
sensing riboswitches [6,7].
From the outset, the application of this purification technique to
a broader variety of molecules proved to be limited by recurrent
technical difficulties such as the precipitation of the TmaM-domain
protein at low salt concentrations, the short lifetime of the resin,
the degradation of RNA molecules in the presence of imidazole,
and the poor cleavage of some sequences by HDV. These
shortcomings were addressed in the next generation of this native
affinity purification technique [8]. In the meantime, we sought to
investigate whether RNA molecules longer than 200 nt could be
purified by the first-generation technique in quality suitable for
both biochemical and crystallization assays.
Here, we report the PCR-based construction from overlapping
primers of six group I intron genes belonging to four different
organisms, as well as the native affinity purification of the
corresponding RNAs (246–341 nt) using the first-generation
method. We present a version of the original protocol that
allowed purification of small-scale transcription reaction products
incorporating radiolabeled nucleotides. These RNAs were sub-
jected to folding assays and catalytic activity assays. We also
applied the standard native affinity purification method to 12
sequence variants of a 287 nt long group I intron from the
bacterium Clostridium botulinum. Crystals were obtained for one of
the circularly permuted variants and were amenable to X-ray
diffraction analysis. Finally, we present the limitations to the
application of this method that were encountered over the course
of this study. Overall, our results indicate that RNAs ranging in
size from 246–341 nt, ending with a 39 overhang of one
nucleotide, and purified using the native affinity technique, could
be successfully used in a wide range of biochemical and structural
assays.
Results
Selection, design and PCR-amplification of variants
The six group I intron RNAs employed in this study originated
from bacteria (Anabaena sp. PCC7120, A.s.; Clostridium botulinum, C.b.;
PLoS ONE | www.plosone.org 1 August 2009 | Volume 4 | Issue 8 | e6740Derbesia marina, D.m.; Bryopsis plumosa, B.p.) [9–11], fungus
(Scytalidium dimidiatum, S.d.) [12], and phage (bacteriophage T4,
td) [13]. A total of 20 DNA templates of various lengths (280–
683 nt) were designed to encode these introns either alone
(designated by ‘‘[I]’’ for ‘‘intron’’; Table 1) or embedded in
exons (designated by ‘‘[P]’’ for precursor; Table 1). For the
Figure 1. A general strategy to synthesize and purify group I introns within the corresponding exons. (A) General scheme of synthesis
by PCR from overlapping primers followed by native purification of the transcribed RNA. The variant shown contains a group I intron (red), 59 and 39
exons (purple), a T7 promoter (blue), and restriction sites suitable for cloning (green). The mutated HDV, the dual SRP tag, and the TmaM protein
coupled to a support are shown in orange, black, and cyan, respectively. Note that the NcoI restriction site was engineered within the 59 end of the
HDV mutant [3], while the BbsI restriction site is no longer present in the final RNA. (B) Affinity purification chart for small-scale transcription reactions
developed in this study (WB: wash buffer; CB: cleavage buffer; SB: storage buffer; RB: regeneration buffer; see Materials and Methods section).
doi:10.1371/journal.pone.0006740.g001
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PLoS ONE | www.plosone.org 2 August 2009 | Volume 4 | Issue 8 | e6740Table 1. Summary of the outcomes of the PCR amplification and of the native purification for each RNA.
Organism [gene type]
1
Variant
abbreviation
2 Variant description
Total length of
variant ligated to
pRAV12 (base
pairs)
3
Method of
synthesis
DNA polymerase
tested
4
Number of
overlapping
DNA primers
Anabaena sp. PCC7120
[tRNA
Leu (UAA)]
A.s.[P] 59 exon: 34 nt; intron: 250 nt;
39 exon: 45 nt (total: 339 nt)
374 PCR from plasmid Herculase n.a.
A.s.[Pm1] 59 exon: 36 nt; intron: 250 nt;
39 exon: 45 nt (total: 341 nt)
376 PCR from
overlapping primers
Taq
*, Pwo, Herculase 8
Derbesia marina
[tRNA
Leu(UAA)]
D.m.[P] 59 exon: 35 nt; intron: 167 nt;
39 exon: 50 nt (total: 252 nt)
287 PCR from
overlapping primers
Taq 6
Bryopsis plumosa
[tRNA
Leu (UAA)]
B.p.[P] 59 exon: 35 nt; intron: 206 nt;
39 exon: 51 nt (total: 292 nt)
327 PCR from
overlapping primers
Taq 7
Bacteriophage T4 [td] td[Pm1] 59 exon: 30 nt; intron: 253 nt;
39 exon: 45 nt (total: 328 nt)
362 PCR from
overlapping primers
Taq, Herculase
* 7
td[Im1] intron: 246 nt 280 PCR from
overlapping primers
Herculase 5
td[I] intron: 257 nt 291 PCR from
overlapping primers
Herculase 5
Scytalidium dimidiatum [SSU] S.d.[P] 59 exon: 30 nt; intron: 393 nt;
39 exon: 45 nt (total: 468 nt)
503 PCR from
overlapping primers
Taq, Pwo, Herculase 10
Clostridium botulinum
[tmRNA]
C.b.[P] 59 exon: 338 nt; intron: 287 nt;
39 exon: 24 nt (total: 649 nt)
683 PCR from plasmid Herculase n.a.
C.b.[Im1–12] intron: 283–290 nt 317–324 PCR from plasmid Herculase n.a.
Fraction of clones
containing the
expected sequence
(out of the total
number tested)
Yield of
cleavage from
support (%)
5
Purity
(%)
5
Amount of
purified RNA
(nmoles/mL
of transcription
reaction)
Successfully
purified using
the nondenaturing
method
GenBank
accession
number Reference
1/1 83
* n.a. n.d. no AJ228705 [11,38]
1/3 38 99 n.d. yes AJ228705
1/4 52
* 99 n.d. yes n.a. K. Kowallik,
pers. comm.
1/4 31
* 99 n.d. yes M61159 [9]
7/15 36
* 91 n.d. yes (td[Pm1b]); no
(td[Pm1a)]
AF158101 [13,37]
4/5 n.d. n.d. n.d yes AF158101
1/2 n.d. n.d. n.d. yes AF158101
0 n.a. n.a. n.a. n.a. AF258603 [12]
1/1 n.a. n.a. n.a. no AM412317 [10]
1/1 3 (C.b. [Im1]) ,5( C.b.[Im1]) n.a. no
18 (C.b.[Im2]) 85 (C.b.[Im2]) 0.5 yes (but low yield)
5( C.b.[Im3]) 75 (C.b.[Im3]) 0.5 no
12 (C.b. [Im4]) 80 (C.b. [Im4]) 0.5 no
63 (C.b. [Im5]) .90 (C.b. [Im5]) 2 yes
30 (C.b. [Im6]) .90 (C.b. [Im6]) 17 yes
73 (C.b. [Im7]) .90 (C.b. [Im7]) 22 yes
79 (C.b. [Im11]) 70 (C.b. [Im11];
small-scale);
.90 (C.b. [Im11];
large scale)
10 yes
.50.0 (C.b. [Im8];
C.b. [Im9];
C.b. [Im10];
C.b. [Im12])
.90 (C.b. [Im8];
C.b. [Im9];
C.b. [Im10];
C.b. [Im12])
24 (C.b.[Im8]);
n.d. (C.b.[Im9]);
20 (C.b.[Im10]);
8( C.b.[Im12])
yes
1tRNA (anticodon); SSU: small ribosomal subunit; td: thymidylate synthase; tmRNA: transfer-messenger RNA.
2P: precursor; Pm1: precursor containing mutations in the tRNA acceptor stem (A.s.)o ri nP 6 a( td); I: intron; Im1: intron containing mutations in P6a; Im1–12: variants #1
to #12 containing mutations in P6a.
3Comprises 35 additional base pairs to the variant sequence, corresponding to restriction sites and a T7 polymerase promoter.
4When two or more polymerases were tested, a star indicates which one was successful.
5See Materials and Methods for calculation details; n.d.: not determined; n.a.: not applicable.
*Estimation based on the amount of cleaved off and uncleaved RNAs present in lanes e1 and r1 only (Fig. 3A; see Materials and Methods).
doi:10.1371/journal.pone.0006740.t001
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D.m., B.p.) or shortened to 75 nucleotides (td, S.d., C.b.). Variants of
the td and C.b. introns were also designed for crystallization
purposes. td[Im] contained a mutated P6a domain (Eric Westhof,
pers. comm.). The C.b.[Im1–12] variants corresponded to 12
variants of the C.b. group I intron that possessed 59 and 39 ends
circularly permuted to the P6a region and further engineered in
both the P6a helix and loop L8 (Figure 2). Circular permutations
of various group I introns had been studied earlier [14,15].
Whereas amplifications of the C.b.[P] and C.b.[Im1–12] variants
were performed by PCR from a plasmid template, all variants
from the A.s., D.m., B.p., and td introns were PCR-amplified from
5–8 primers that were 65–85 nt long and overlapping by 15–20 nt
(Tables 1 and S1). These variants were obtained using either the
Taq or Herculase DNA polymerases, after one or two rounds of
PCR (Table 1; Figure S1). Attempts to synthesize the S.d.[P]
template at different temperatures (50–65uC) and using the three
different DNA polymerases were unsuccessful; the only achieve-
ment was a PCR product containing the first 200 nt of the
expected sequence (Figure S1). The failure of the S.d.[P] template
to be engineered by this technique could be accounted for by a
combination of its length (503 base pairs)—thus increasing the
number of overlapping primers to 10 (Table 1)—and of its high
GC content (68%; the GC content of the A.s.[P], D.m.[P], B.p.[P],
td[P] templates is 43%, 27%, 26% and 42%, respectively).
PCR-amplification from overlapping primers randomly gener-
ated mutations within or close to the overlapping regions.
Typically, only 25% of the clones sequenced following ligation
to the pRAV12 plasmid contained the expected sequence
(Table 1). Using higher amounts of template (100–1000 ng)
[16] and site-directed mutagenesis with primers to reintroduce the
correct sequence [17] offered potential solutions that were not
pursued here. Instead, switching to a higher fidelity polymerase
like Herculase (Stratagene) increased the percentage of correct
sequences to 50%, even when performing the two-round PCR
amplification procedure (compare for example td[Pm1] to td[I];
Table 1). Finally, two mutants of the td[Pm1] template (td[Pm1a]
and td[Pm1b]) that resulted from random PCR errors were further
transcribed and purified. The corresponding RNAs were shown to
retain some activity (see below). In summary, the templates that
were optimally synthesized were about 300 nucleotides long
(corresponding to five overlapping primers) and were amplified in
one round using a high-fidelity DNA polymerase.
Native purification of 246–341 nucleotide-long RNAs
The preparation of the TmaM protein and its coupling to a
support to generate the affinity resin were performed as described
[3]. However, the original purification procedure [3] was here
optimized for small-scale transcription reactions by employing spin
columns and a table top microcentrifuge (Figure 1B). These
adjustments made it possible to purify six transcription reactions of
25 mL each in about 3 hours, using 150 mL of affinity resin. This
implementation was performed independently of the development
of a similar one based on the second generation purification
method [8].
More than 75% of the full-length transcript is typically retained
on the resin (as estimated by comparing the number of counts of
the corresponding band in the flow-through lane to that in the
transcription reaction lane; respectively lanes f and X/G in
Figures 3B and S3). In the end, 15 out of the 21 natural and
mutant RNAs were eluted with an average yield of 53% (the
standard deviation is 17%; Table 1), to a purity .90% (up to 99%
for A.s.[Pm1], B.p.[P], and D.m.[P]; Table 1). These values are
roughly in line with earlier estimates for 49-nt and 160-nt long
RNAs purified on a large scale [3]. Although some moderate (10–
30%) and extreme (.80%) cleavage yields may be a consequence
of the assumptions made for the calculation (see Materials and
Methods), the majority of the cleavage yields can be correlated to
the secondary structure at the cleavage site, as suggested earlier
[8], regardless of the scale of the purification. In particular, all
sequences possessing a 39 overhang of at least one nucleotide are
cleaved with efficiencies .30% (e.g., B.p.[P], D.m.[P], A.s.[P],
C.b.[Im5]), while variants possessing no overhang (e.g., C.b.[Im1],
C.b.[Im2]) or a 59 overhang (C.b.[Im3]) give moderate to low
(,10%) cleavage yields (Table 1, Figure 3). C.b.[Im4] was an
exception to this rule, as only 12% were cleaved by HDV, in spite
of the two-nucleotide 39 overhang (Table 1; Figure 3B). As a
rationale for this observation, we propose that for a large fraction
of these molecules, the two dangling cytosines would pair with two
of the guanines at positions 38–40 in the joining region J1/4 of the
HDV. The formation of such long-range interactions would likely
interfere with folding of the ribozyme active site [18,19]. Hence,
the subsequent C.b.[Im6–12] variants all incorporated a 39
dangling adenine or uridine (Figure 2) and were cleaved off by
HDV with .50% efficiencies (Table 1; Figures 3B and S2).
Typically, the higher the cleavage yield, the higher the purity
(Table 1), as a high cleavage yield leads to a higher fraction of the
expected RNA among degradation products that result from the
incubation step in the presence of imidazole [3].
The efficiency of the native purification method was
compared to that of a standard denaturing gel purification
technique for a subset of the RNAs (See Materials and Methods).
The number of counts per minute (cpm) measured using a
scintillation counter for 1.0 mL of the natively purified radiola-
beled A.s.[Pm1] and td[Pm1b] RNA solutions was in the same
50,000–100,000 range as that obtained for RNAs purified using
the conventional denaturing technique (side-by-side comparison
for A.s.[Pm1] and comparison with other radiolabeled group I
intron variants transcribed in similar conditions [23]). Addition-
ally, molar amounts per mL of transcription reaction were
estimated for the C.b. variants prepared using the large-scale
affinity purification. These were typically comprised between
2.0 nmoles/mL (C.b.[Im5]; Table 1) and 24 nmoles/mL
(C.b.[Im8]; Table 1), corresponding to 1.0–12.0 mg of RNA
purified from a 5.0 mL transcription reaction. Here as well,
these yields were similar to that obtained from the denaturing
technique: 3.0–14.0 nmoles/mL of transcription reaction, as
estimated for two batches of the C.b.[Im1] RNA and one batch of
the C.b.[Im3] RNA. In short, both the small and the large-scale
native purification methods are competitive with a conventional
denaturing technique for a quantitative preparation of RNA. All
the successfully purified RNAs (Table 1) were further used in
biochemical assays aimed at characterizing their folding,
catalytic, and structural properties.
Of the three RNAs that could not be satisfactorily purified, one
had the longest sequence tested (C.b.[P]: 683 nt; Figure 3A), and
two self-spliced or hydrolyzed during the purification, indicating
that this method was not suitable for the purification of certain self-
splicingintrons(A.s.[P],Figure3A;td[Pm1a],Figure4A–B).Inan
attempt to inhibit self-splicing and metal-ion mediated hydrolysis
during purification, we tested the efficiency of the purification
method at conditions that decrease pH (6.5, 7.0 or 7.5), lower the
magnesium concentration (2 mM instead of 10 mM), or replace
magnesiumions bycalcium ions (only the composition ofthe buffers
used for the native purification were modified accordingly). The
quality of the purification was assessed for a mutant of the A.s.[P]
variant transcribed in standard conditions (A.s.[Pm1]; Table 1). At
2 mM MgCl2, the recovered A.s.[Pm1] variant was only 75% pure
Native Purification of Introns
PLoS ONE | www.plosone.org 4 August 2009 | Volume 4 | Issue 8 | e6740Figure 2. Predicted secondary structure of the Clostridium botulinum intron variants used in this study. Base pairing within long-range
interactions and structural motifs is shown using the Leontis and Westhof nomenclature [40], where circles denote interactions involving the Watson-
Crick face, squares the Hoogsteen face, and triangles the sugar edge. The different sequences of the P6a stem in the twelve mutants are shown in the
blue box (wild type sequence and topology shown in the inset for comparison). The substrate oligonucleotide is shown in green.
doi:10.1371/journal.pone.0006740.g002
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PLoS ONE | www.plosone.org 5 August 2009 | Volume 4 | Issue 8 | e6740Figure 3. Native affinity purification of various RNAs as visualized by denaturing PAGE. (A) Purification of precursor RNAs each
containing an intron with both exons. The intermediate product of the A.s.[P] intron could be the 59 exon followed by the intron (product of
hydrolysis at the 39 splice site), or the intron followed by the 39 exon (product of self-splicing). Labels above each lane refer to purification steps
detailed in Figure 1B (X: transcription reaction; l1–2: load #1–2; f: final flow-through; w1–7: wash #1–7; e1–3: elution #1–3; r1–5: regeneration #1–5).
The various products are indicated on the right side of each gel. In this and subsequent figures, the expected product is underlined. (B) Purification of
C.b. intron variants (nomenclature as in panel A). Note that all the gels in panel A and the gel of C.b.[Im11] in panel B show radiolabeled RNA whereas
the gels of C.b.[Im1–5] in panel B depict unlabeled RNA (i.e. the gels were stained before being scanned). These gels were not adjusted for contrast.
doi:10.1371/journal.pone.0006740.g003
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that lower magnesium concentration (Figure S3). Hence, that
condition was not employed for the purification of other sequences.
The other attempts failed to purify the A.s.[Pm1] variant
(yields,10%, together with severe degradation), in spite of .75%
binding to the resin (Figure S3).
Folding and catalytic activity assays
td and C.b. variants solely containing the intron were annealed
in the presence of a substrate oligonucleotide designed to form the
P1 helix [20]. Similar complexes were previously crystallized using
such strategies [21,22]. In our case, the sequences of the substrate
oligonucleotides were 59-UUGGGU-39 for the td intron, and
either 59-CGAU-39 or 59-CGAdT-39 for the C.b. variants.
Prior to crystallization assays, we first tested for folding
homogeneity of denaturing PAGE-purified C.b. intron variants by
native gel electrophoresis, in absence and in presence of the
substrate oligonucleotide. A single sharp band was taken to indicate
a homogeneously folded molecule. According to this criterion, the
PAGE-purified circularly permuted C.b.[Im1] RNA was folded
similarly to the PAGE-purified wild type molecule (Figure 5A),
both in absence and in presence of the 59-CGAU-39 oligonucleotide
(Figure 5B). Similarly, native gel experiments showed that the
affinity-purified td[I] and td[Im1] RNAs were folded homogeneous-
ly in absence as well as in presence of increasing concentrations of
the substrate strand (Figure 4C). Finally, as anticipated, compar-
ison of various refolding protocols for three affinity-purified variants
(C.b.[Im1], C.b.[Im3], and C.b.[Im11]) indicated that the RNAs in
absence and in presence of the 59-CGAdT-39 oligonucleotide were
folded after native purification, without the need of any additional
annealing protocol (compare condition #1 to the other conditions;
Figure 5C). In fact, some annealing protocols promoted RNA
degradation (see condition #10 for the C.b.[Im11] variant,
corresponding to an incubation for 3 min at 85uC followed by the
addition of 15 mM MgCl2; Figure 5C).
The B.p.[P], D.m.[P], and td[Pm1b] RNAs were assayed for self-
splicing activity using conditions recently compiled to test for self-
splicing activity in a comprehensive manner [23]. Self-splicing
could not be detected for the partially degraded B.p.[P] and
D.m.[P] introns (Figure S4). The td[Pm1b] variant that contains
the A918G mutation and the deletion of G78 was self-splicing,
although the second step of the self-splicing reaction was only 50%
at best after 1 hour (Figure 4A,D).
Crystallization of a variant of the Clostridium botulinum
intron
All td and C.b. variants were assayed by conventional RNA
crystallization methods using crystallization screens and either the
vapor diffusion technique [24,25], or the free interface diffusion
technique within a micro-chip [26]. Plate clusters of the
C.b.[Im11] variant were observed after three days at 16uC in the
micro-chip, in condition #26 of the PEG/Ion screen (Hampton
Research; 10 mM RNA, 12.5 mM5 9-CGAdT-39, 20% PEG 3350,
200 mM Zn acetate) (Figure 6A). Crystals could not be
reproduced under these conditions by hanging drop vapor
diffusion. However, the same variant crystallized by vapor
diffusion after 3 days at 30uC in the following conditions:
20 mM RNA, 25 mM5 9-CGAdT-39, 10% MPD, 0–80 mM
NaCl/KCl, 1 mM Co
3+ hexamine, 20 mM MgCl2, 0–1 mM
spermine-HCl, 40 mM Na cacodylate pH 5.5 (drop solution);
25% MPD (well solution). In these conditions, single crystals grew
to sizes suitable for diffraction analysis (Figure 6B).
The resolution of the C.b.[Im11] crystals was ,10 A ˚ on the CuKa
X-ray home source (I/s=1.9 and R merge=32.4% for the 10.6–
10.1 A ˚ resolution bin).The space group was trigonal (P3 family), with
cell parameters a=194.1 A ˚, b=194.1 A ˚,c = 4 1 5 . 5A ˚, a=b=90u,
c=120u. The resolution improved slightly at a synchrotron, to ,8.0–
8.5 A ˚ (Figure S5A). Because we were unable to reduce the data
collected at the synchrotron, we sought out to obtain crystalsusing the
C.b.[Im11] variant purified by a conventional denaturing polyacryl-
amide gel electrophoresis (PAGE) technique.
The crystals of the PAGE-purified C.b.[Im11] variant looked
similar to that of their natively-purified counterparts, although
they tended to have sharper edges (Figure 6B). In spite of this
somewhat different morphology, these crystals belonged to the
same space group and diffracted in 90% of the cases within the
same resolution range as the crystals obtained from natively
purified RNA. In the remaining 10% of the cases, we observed a
higher resolution at a synchrotron, ,7.0–7.5 A ˚ (I/s=1.6 and
Rmerge=46.8% for the 8.02–6.96 A ˚ resolution bin; Figure S5A).
Since about 10 times more crystals of the PAGE-purified RNA
were tested than of the natively purified RNA, it cannot be ruled
out that similar resolutions could have been achieved with crystals
of the natively purified RNA. It is also possible that original
crystals of the natively-purified RNA were grown from a solution
that contained partially degraded RNA. In fact, in order to
preserve the native folding of this intron, we initially stored the
RNA at 4uC in the presence of 5 mM MgCl2 (in 10 mM Na
cacodylate pH 5.0). We later found out that storage of the RNA at
4uC even in 1 mM MgCl2 was inducing severe degradation after a
few weeks (Figure S6). We subsequently stored the RNA at
220uC in absence or in presence of 1 mM MgCl2, at pH 5.0,
which did not promote RNA degradation (Figure S6) nor altered
the folding. Finally, spherulites and urchins were obtained in
similar conditions for two other variants purified by PAGE,
C.b.[Im3] and C.b.[Im8] (Figure S5B; the natively purified
C.b.[Im3] and C.b.[Im8] variants had not been extensively assayed
for crystallization). In any case, attempts at annealing crystals to
increase resolution [27,28] were unsuccessful. Furthermore, all
crystals tested suffered from severe radiation damage, regardless of
the RNA purification method and of the cryoprotecting condition,
leading to rapid loss in resolution during data collection.
Discussion
23 group I intron variants ranging in length from 246 to 341 nt
were transcribed and subjected to purification using a non-
denaturing affinity purification method. The original protocol [3]
was adjusted to allow purification of small-scale transcription
reactions. Using this technique, the overall time required for the
production of six samples in parallel was less than two days.
Besides the advantages of the native purification previously
emphasized [3], two factors were critical to attaining such a fast
time scale. First, the sequence of the DNA template was split into
five primers that could be amplified altogether in one round of
PCR using a high-fidelity DNA polymerase. Although successful
amplification of 6–8 overlapping primers was achieved, these
products tended to contain a higher frequency of random
mutations. Noteworthy, we were unable to amplify the only
sequence in our screen that was made of 10 overlapping primers.
These observations expand on previous reports of PCR synthesis
from overlapping oligonucleotides of 100–150 nt long sequences
[29]. Second, a 39 overhang of one nucleotide introduced in the
series of the C.b.[Im6–12] variants enabled optimal cleavage by
HDV. The sequence of this overhang did not seem to be critical,
as variants ending with a single A (e.g. A.s.[Pm1], C.b.[Im6] and
C.b.[Im11]; Figures 3B, S2 and S3), a single U (e.g. C.b.[Im10];
Figure S2), a single C (e.g. C.b.[Im5]; Figure 3B) were efficiently
Native Purification of Introns
PLoS ONE | www.plosone.org 7 August 2009 | Volume 4 | Issue 8 | e6740Figure 4. Self-splicing and folding assays of td intron variants. (A) Predicted secondary structure of the td[Pm1a] and td[Pm1b] mutants. The
mutations corresponding to each variant are shown in colors (red, td[Pm1a]; green, td[Pm1b]). (B) Purification of td[Pm1a] showing simultaneous self-
splicing. (C)Folding of the td[I] andtd[Im] variants in the presence of increasing concentrationof the substrate oligonucleotide (sequence shownin blue
on the schematized secondary structure diagrams), as visualized by native PAGE. The different sequences of the P6a regions possessed by the two
variantsarespecifiedonsecondarystructurediagrams.(D)Self-splicingactivityoftd[Pm1b]underfivedifferentbufferconditions(seeMethodsand[23]).
doi:10.1371/journal.pone.0006740.g004
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the overhang of C.b.[Im4] containing two cytidines likely
interfered with folding of the HDV ribozyme, resulting in poor
cleavage (Figure 3B; Table 1). Overall, when this fast
preparation of pure RNA was coupled to crystallization assays
for which we used the free interface diffusion system, the time span
between RNA molecule design and in-chip crystal observation was
under two weeks. This represents a faster timeline than when
applying conventional methods [25], particularly when working
with RNAs of that size.
Although it was not completely clear from our data whether the
quality of the natively-purified and the PAGE-purified C.b.[Im11]
RNAs were the same, both RNAs crystallized under the same
conditions and the crystals looked similar. This encouraging
observation suggested that this purification method would be
suitable for a fast screening of several crystallization variants
during the initial screening steps, even for sequences about 300 nt
long. Furthermore, if results of such a screening ended up being
ambiguous, the PAGE-purification of some of the most promising
variants could always be chosen as part of the optimization
strategy. Although RNAs of this length have not yet been tested
with the updated version of the purification scheme [8], the
purification efficiency should be similar. In particular, we expect
that the elimination of the incubation step in the presence of
Figure 5. Folding assays of C. botulinum intron variants. (A) Folding of the PAGE-purified wild type and the C.b.[Im1] introns after incubation
for either 5 min or 1.5 h in two buffer conditions, in the presence or absence of 0.1 mM GMP (see Methods and [23]), and visualized by native PAGE.
The wild type intron contained an 8 nt-long 59 exon and a 7-nt long 39 exon. (B) Comparison of the migration by native PAGE of the PAGE-purified
C.b.[Im1] variant after incubation for 1.5 h in buffer A (see Methods), either in absence (lane 1) or in presence of 100 mM of a substrate
oligonucleotide (lane 2). (C) Folding of three natively purified C.b. variants under different annealing protocols, as follows (all conditions in 10 mM Na
cacodylate pH 6.5): 1,2mM RNA, no annealing protocol; 2,2mM RNA, 2.5 mM5 9-CGAdT-39, no annealing protocol; 3, same as 2 but at 15 mM MgCl2,
25 mM NaCl; 4, same as 2 but at 1.0 mM MgCl2; 5, same as 1 but at trace [RNA]; 6, same as 1 but incubated for 3 min at 85uC, for 1 min at 25uC,
followed by addition of 15 mM MgCl2; 7, same as 2 but annealed like 6; 8, same as 3 but incubated for 10 min at 50uC, and for 10 min at 4uC; 9, same
as 4 but annealed like 8; 10, same as 5 but annealed like 6. The native gel was run at 15 mM MgCl2, 25 mM NaCl.
doi:10.1371/journal.pone.0006740.g005
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molecules, since it should limit RNA degradation. Finally, special
care should be given to the storage condition of the natively-
purified molecules, so that the native structure would be preserved
while the metal ion-mediated degradation of the RNA would be
minimized.
Even when following these recommendations, this purification
method may not be suitable for all RNAs, particularly autocat-
alytic molecules. For example, some precursor RNAs (e.g. the
A.s.[P] and the td[Pm1a] variants; Figures 3A and 4A)
hydrolyzed or self-spliced over the course of the purification
process, which occurs at 10 mM MgCl2 and may contain some
traces of GTP employed during transcription (Figure 1B).
Performing the purification at 2 mM MgCl2 may be sufficient to
reduce self-splicing for some introns, although such a lower
magnesium concentration may additionally result in poorer yields
of pure RNA (Figure S3). Fortunately, not all introns self-cleaved
during the purification procedure (e.g. the td[Pm1b] variant;
Figure 4D), likely because a condition that favors hydrolysis or
self-splicing for one intron may not have the same effect on
another intron [23]. Consequently, the purification system needs
to be tested on a case-by-case basis. Because of the rapid timeline
by which results are obtained, reverting to a conventional
purification method would happen in a timely manner.
Finally, the coupling of the PCR strategy employed here and of
the native purification method could help engineer random
mutations in the specific regions of RNA molecules about 300 nt
long (i.e. by including such areas within the overlap regions). Such
mutants may lead to improvement in crystallization, as mutation
of one nucleotide often strongly affects resolution [30]. In our case,
such mutations resulted in td mutants that unexpectedly retained
some activity. The td[Pm1a] RNA self-spliced over the course of
the purification, indicating that the two base substitutions in the L1
loop and in the P6a stem did not hamper activity (Figure 4A–B).
Self-splicing of the td[Pm1b] RNA was initially unforeseen, as the
deletion of G78 normally paired to C865 at the first position of the
P6 helix (P6-bp1) likely disrupted the corresponding base triple
involving P6 and the J3/4 junction in all group I introns [31].
However, mutation of G to C at position 78 [32] and of the
adjacent C to U at position 79 [33] had been shown to have a
similar effect on splicing. Similarly to the partial suppression of the
C79U mutation observed upon addition of the CYT-18 protein
[34,35], it could be worth investigating whether the activity of the
td intron deprived of G78 could be rescued by the CYT-18 protein
or by the StpA protein, which also binds to this location [36].
Concluding remarks
While developing a second generation of the affinity purification
method [8], we showed that by using the first generation method
we successfully purified RNA molecules as long as ,341 nt. These
RNAs retained a folded structure that enabled them to be active in
self-splicing assays. One variant of the Clostridium botulinum intron
gave crystals of a similar quality than crystals obtained using a
conventional denaturing purification technique, although the time
span to obtain the RNA was significantly reduced. Together, the
first and the second generation of the purification techniques may
constitute unique tools for the preparation of co-transcriptionally
folded RNAs of a large size.
Materials and Methods
Intron selection and construct design
Group I introns were selected based on their length (ranging
from 167 nt to 393 nt), their exon context (three tRNA
Leu introns,
one ribosomal intron, one tmRNA intron, and one intron in a
protein coding sequence), and other properties relating to the
purpose of this study. For example, three introns (A.s., td, C.b.) had
been previously shown to be self-splicing [11,13,23] and were used
to test the efficiency of the purification method. Constructs were
designed that incorporated the intron embedded in both exons,
either at their natural length (for tRNA and tmRNA exons), or
shortened to tRNA-like lengths (for td and S.d. exons). Additional
variants were synthesized to incorporate the intron only, for td (two
variants missing the first seven nucleotides [20] and containing
shortened P6a regions [37]) and C.b. (12 circularly permuted
variants possessing diverse P6a regions).
Constructs were designed to incorporate the following sequence:
six random nucleotides, a restriction site for cloning at the 59 end
(EcoRI), the T7 polymerase promoter 59-TAATACGACTCAC-
TATA-39, three guanosine residues,the nucleotides corresponding to
the 59 exon (when appropriate; Table 1), the intron, the nucleotides
corresponding to the 39 exon (when appropriate; Table 1), a
restriction site for cloning and/or linearization at the 39 end (BbsI or
Figure 6. Crystals of the C.b.[Im11] variant. (A) Plate cluster
observed in a chamber of a micro-chip. (B) Comparison of crystals
obtained from natively purified RNA (top) and from RNA obtained by
conventional gel purification (bottom). The scale bar corresponds to
100 mm in all panels.
doi:10.1371/journal.pone.0006740.g006
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five to ten 65–85-nucleotide long DNA primersthat were overlapping
by 15–20 nucleotides (note: approximately half of these primers
would hereby contain the sequence of the complementary strand)
(Table S1). Polymerase chain reactions (PCR) from overlapping
DNA primers spanning an entire gene thus offered an alternative to
cloning genomic DNA [16,17].
Multi-round PCR strategy
For the first round of PCR, constructs were amplified in 50 mL-
reaction mixes containing: 0.4 pmoles of each overlapping primer
(,10 ng); 200–250 mM each dNTP; 1.0 mM MgCl2; either 0.5 U
Taq DNA polymerase (Roche #11 146 165 001), or 0.5 U Pwo
DNA polymerase (Inno-Train Diagnostik GbmH #GX02010), or
2.5 U Herculase DNA polymerase (Stratagene #600262); 1X
reaction buffer supplied by the manufacturer. PCR were
performed in a Robocycler Gradient 96 apparatus (Stratagene)
using the following protocol: 4 min at 94uC (1 cycle); 55 s at 94uC,
55 s at 50–65uC, 1.5 min at 72uC (30–35 cycles); 10 min at 72uC
(1 cycle). When only one round of PCR was necessary, these
conditions were employed, in the presence of the generic primers
described below for the second round.
When a second round of PCR was necessary, PCR products
from the first round were combined as follows in 50 mL-reaction
mixes: 20 mL of each of the two sets of amplified portions from the
first round necessary to obtain the complete sequence of the
construct (e.g. for the td[P] construct: 20 mL of the amplified
primers 124+20 mL of the amplified primers 3–7); 50 pmoles of
each of the two generic primers (containing the first 25–30
nucleotides of the first and the last overlapping primer); 200–
250 mM each dNTP; 1.0 mM MgCl2; either 0.5 U Taq DNA
polymerase (Roche #11 146 165 001), or 0.5 U Pwo DNA
polymerase (Inno-Train Diagnostik GbmH #GX02010), or 2.5 U
Herculase DNA polymerase (Stratagene #600262); 1X reaction
buffer supplied by the manufacturer. PCR were performed in a
Robocycler Gradient 96 apparatus (Stratagene) using the same
cycles as for round #1. The A.s.[Pm1], D.m.[P] and B.p.[P]
variants were subsequently amplified for a third round in presence
of a primer replacing the BbsI restriction site by a NcoI/NgoMIV
site (see below; ‘As-Ngo’ and ‘Dm/Bp-Ngo’ primers, Table S1).
All PCR products were monitored by electrophoresis on 1% or
1.5% agarose gels run using 1X TAE buffer (40 mM Tris-acetate
pH 8.0; 1.0 mM EDTA). Gels were stained using ethidium
bromide (Sigma #46067-50ML-F) and visualized using a UV-
light transilluminator.
Cloning procedure and transformation
The PCR amplified products were purified using the QIAquick
PCR purification kit (Qiagen #28104), and digested using the
appropriate restriction enzymes (EcoRI, New England Biolabs
(NEB) #R0101L; and NcoI, NEB #R0193L—incomplete
digestion products were typically obtained using BbsI, NEB
#R0539L, which made us avoid using this enzyme). The digested
products were then purified by agarose gel electrophoresis, and
eluted in a final volume of 30 mL using the QIAquick gel
extraction kit (Qiagen #28706). Ligation occurred for 35 min at
room temperature (,23–25uC) in a solution containing: 0.2 mg/
mL pRAV12 vector [3]; 50–100 ng/mL PCR product; 400 U T4
DNA ligase (NEB #M0202S); 1X reaction buffer supplied by the
manufacturer. The pRAV12 vector had been previously digested
using the EcoRI and NcoI or NgoMIV restriction enzymes and
dephosphorylated using 1.0 U calf intestine alkaline phosphatase
(Roche #713023) for 30 min at 37uC followed by 20 min at 70uC.
1.0 mL of the ligation reaction mix was used to transform 10 mLo f
Solopack Gold Supercompetent cells (Stratagene #230350).
Transformation was performed using the following protocol:
20 min at 4uC; 1 min at 54uC; addition of LB (-Amp) broth;
incubation on LB (+Amp) plates for 16–20 h at 37uC. Alterna-
tively, 1.0 mL of the ligation reaction mix was used to transform
40 mL of XL1-Blue electroporation-competent cells (Stratagene
#200228). Electroporation was performed according to the
manufacturer’s protocol, using 0.1-cm gap cuvettes (Bio-Rad
#165-2083EDU) and a Bio-Rad Gene Pulser set to a 200 V
resistance, and a 25 mF capacity. In both cases, plasmids
possessing the expected sequence were purified using the QIAprep
spin miniprep kit (Qiagen #27106) from 3–5 mL LB cultures
grown for 16–20 h at 37uC.
The C.b.[P] and the A.s.[P] constructs were independently
amplified from plasmids containing the intron and the complete
exons (for C.b.[P]: p237AK, gift from K. Williams; for A.s.[P]:
pAtRNA-1, [38]), using the generic primers and 2.5 U Herculase
DNA polymerase (similar strategy as described for the second
round of PCR above). The C.b.[Im1] variant was amplified from
the p237AK plasmid using a two-step PCR strategy that would
circularly permute the 59 and 39 ends into the P6a region (Figure
S7). Each PCR step was performed under the reaction conditions
described above. The PCR products of the first step were diluted
by 10-fold and 1 mL of this dilution was used as a template into a
final 50 mL-reaction mix for the second step. The various 59 and
39 ends of the C.b.[Im2–12] variants (Figure 2) were added by
PCR using C.b.[Im1] as a template and the primers reported in
Table S1. The C.b.[P], A.s.[P] and C.b.[Im1–12] constructs were
ligated into pRAV12 and expressed according to the procedure
described above.
In vitro transcription of body-labeled RNAs
Plasmids were linearized using the BamHI restriction enzyme
(NEB #R0136L) and were transcribed for 1 h at 37uCi n2 5mL-
reaction mixes containing: 1.0–4.0 mg/mL linearized plasmid;
50 mCi a-
32P ATP (PerkinElmer); 4.0 mM each rNTP; 12.0 mM
MgCl2; 2.0 mM spermidine-HCl; 10 mM DTT; 0.1% Triton X-
100; 4.0 ng/mL inorganic pyrophosphatase (Sigma #I1891-
100UN); 40 U RNasin Plus RNase inhibitor (Promega
#N261B); 2 mL T7 RNA polymerase (prepared in house);
50 mM Tris-HCl pH 7.5. The final radioactivity of the samples
was measured by the number of counts per minute (cpm) for
1.0 mL of the RNA solution diluted into 3.0 mL ScintiSafe Econo
1 solution (Fisher Scientific #SX20-5), obtained using a
scintillation counter (Beckman #LS3801).
In vitro transcription of unlabeled RNAs
Linearized plasmids each containing one of the C.b.[Im1–12],
td[I], or td[Im1] variants were transcribed in a similar reaction
solution, but for 2 h at 37uC and in 1.5 mL–10.0 mL reaction
mixes. Concentrations of the purified products were determined
from the A260 and calculated extinction coefficients based on the
nucleotide sequence (using for example a resource such as the
following: http://www.basic.northwestern.edu/biotools/oligocalc.
html). The RNAs were concentrated to ,500 mM using a
centrifugal filter unit with a 10,000 MWCO (Millipore,
UFC801008), and stored at 4uCo ra t220uC in a buffer
containing either 50 mM Na HEPES pH 7.5, 25 mM NaCl,
15 mM MgCl2, or 10 mM Na cacodylate pH 5.0–6.5, 10 mM
NaCl and 0–5 mM MgCl2. The C.b. RNAs were used in
crystallization assays without prior refolding, while the td variants
were annealed for 10 min at 37uC prior to being utilized in
crystallization assays.
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The gel-purified C.b.[Im1–12] variants used as a control for the
crystallization and X-ray diffraction experiments were transcribed
by run-off transcription from a plasmid linearized using the FokI
enzyme (NEB #R0109S), as described above, but for 4 h at 37uC
and in 10 mL-reaction mixes. The RNAs were ethanol precipi-
tated for 16 h at 220uC in 70% EtOH, 100 mM Na acetate
pH 5.3, centrifugated for 35 min at 13,500 g, dried for 10 min
under vacuum (SpeedVac), and purified by denaturing gel
electrophoresis (6% acrylamide/bisacrylamide [29:1]; 8.0 M urea;
1X TBE). The gel slice corresponding to the RNA was crushed
and soaked for 2 h at 4uC in 35 mL of an elution buffer
containing: 1.0 mM EDTA; 10 mM Tris-HCl pH 7.5. The
solution was filtered through a 0.2 mm filter, and concentrated
to ,200 mM using a centrifugal filter unit with a 30,000 MWCO
(Millipore #UFC903096), and stored at 4uCo r220uC in a buffer
containing 10 mM Na cacodylate pH 6.5, 10 mM NaCl and
5 mM MgCl2. The RNAs were used in crystallization assays
without prior annealing.
A similar procedure was applied to a 25 mL-run off transcrip-
tion reaction of the radiolabeled A.s.[Pm1] RNA that was deprived
of the affinity tag. Here, the gel slice corresponding to the
A.s.[Pm1] RNA was crushed and soaked for 20 h (with one buffer
exchange after 2 h) at 4uC in 800 mL of an elution buffer
containing: 1.0 mM EDTA; 250 mM NaCl; 10 mM Tris-HCl
pH 7.5. Precipitation and filtration were performed as described
in the previous paragraph, and the RNA was stored at 220uCi n
water. The final radioactivity of the RNA was measured as
described in the section entitled: ‘‘In vitro transcription of body-labeled
RNAs’’.
Preparation of the TmaM affinity matrix
The TmaM protein was prepared and coupled to the activated
support as described [3] (Figure S8). Over the course of this
preparation, similar problems to that later reported were observed,
including for example the precipitation of the protein after its
concentration [8]. Attempts to refold the protein in 8.0 M urea at
various temperatures (37uC, 50uC, 70uC) were unsuccessful.
Nondenaturing purification of the transcripts
The body-labeled transcription products were purified by
nondenaturing purification as described [3], with the modifica-
tions mentioned in Figure 2. G-25 Sephadex quick spin columns
(Roche #1 273 990) and spin columns (Qiagen #79523 or Pierce
#29924) were employed during the purification. Buffers used were
as follows [3]: wash buffer (WB), 10 mM MgCl2, 250 mM NaCl,
25 mM Tris-HCl pH 8.0; cleavage buffer (CB), 10 mM MgCl2,
250 mM NaCl, 200 mM imidazole, 25 mM Tris-HCl pH 8.0;
regeneration buffer (RB), 1.0 M LiCl, 174 mM glacial acetic acid,
25 mM Na2EDTA; storage buffer (SB), WB containing 0.1% Na
azide.
The unlabeled transcription products of the C.b.[Im1–12]
variants were purified without modification of the published
protocol (except for adjustments to the corresponding transcription
reaction volumes) [3].
Products from the purification were analyzed by electrophoresis
on denaturing gels (6% acrylamide/bisacrylamide [19:1]; 7.0 M
urea; 1X TBE: 100 mM Tris-base, 83 mM boric acid, 1.0 mM
EDTA). Care was taken to load gels with volumes of samples
proportional to the total volume of each fraction (except for the
C.b.[Im1–12] variants). The gels were either stained using SYBR
Green II RNA gel stain (Invitrogen, #S-7568; only for the
C.b.[Im1–12] variants), or dried under vacuum and placed for 18–
30 h in phosphorimager screens (Molecular Dynamics). Both the
stained gels and the screens were scanned using a phosphorimager
(Amersham Bioscience/GE) and the gel images were analyzed
using ImageQuant TL v. 2005 (Amersham Bioscience/GE).
An approximate yield of cleavage from the resin was estimated
by calculating the average between y1 = [(N1/26)/((N1/26) +
(N2/nA2)] 6 100 and y2 = [(N3/nA3)/((N3/nA3) + (N2/nA2)] x
100, where:
N1=number of counts in the band corresponding to the tag
removed from the support during the regeneration steps (found in
lanes ‘‘r1–r5’’ on Fig. 3, S2 and S3);
N2=number of counts in the band corresponding to the
uncleaved RNA removed from the support during the regener-
ation steps (found in lanes ‘‘r1–r5’’ on Fig. 3, S2 and S3);
N3=number of counts in the band corresponding to the RNA
cleaved off from the support during the elution steps (found in
lanes ‘‘e1–e5’’ and/or ‘‘pool A/B’’ on Fig. 3, S2 and S3);
nA2=number of adenines in the precursor/intron+tag RNA
(the tag contains 26 adenines);
nA3=number of adenines in the precursor/intron RNA (110,
A.s.[P] and A.s.[Pm1]; 95, D.m.[P]; 107, B.p.[P]; 78, td[Pm1]; 98,
C.b.[Im11]).
Purity was estimated by the ratio [(N3/(N3+Ntotal)] 6 100,
where N3 is as described above, and:
Ntotal=total number of counts other than N3 (found in lanes
‘‘e1–e5’’ and/or ‘‘pool A/B’’ on Fig. 3, S2 and S3);
All the corresponding lanes shown in Figs. 3, S2 and S3 were
used for quantification. In the cases shown in Figs. 2 and S3, the
volumes loaded on the gels were proportional to the total fraction
volumes. In the gels shown on Fig. S2, the number of counts were
normalized to take into account differences in the ratios of volume
loaded on the gel/total fraction volume. All elution and
regeneration fractions were used to calculate the yields of the
variants displayed on Figs. 3B, S2, S3. Noteworthy, the yields for
A.s.[P], D.m.[P], B.p.[P], and td[Pm1] were calculated using the
amounts of cleaved off and uncleaved RNAs present in lanes e1
and r1 only (Fig. 3A). Based on the yields for A.s.[Pm1] and the
C.b. variants it was assumed that .70% of the product is recovered
during the first elution step and .70% of the uncleaved RNA is
removed from the resin during the first regeneration step
(Table 1; Fig. 3A).
Folding assays
Approximately 2,000 cpm of the body-labeled wild-type C.
botulinum intron and of the C.b.[Im1] variant purified by
denaturing PAGE were annealed for 3 min at 50uC followed by
10 min at 32uC in 25 mM Na HEPES pH 7.5 [38], before
addition of solution A or C (see Self-splicing assays section below)
and further incubation for 5 min or 1.5 h at 32uC. A sample of the
C.b.[Im1] variant was also similarly incubated in the presence of
100 mM5 9-CGAU-39.
Approximately 20,000 cpm of the C.b.[Im1], C.b.[Im3] and
C.b.[Im11] variants natively purified were incubated according to
different annealing protocols, as described in the legend to Figure 5
(all conditions in 10 mM Na cacodylate pH 6.5).
Approximately 5,000 cpm of the body-labeled td[I] and td[Im]
RNAs were annealed for 10 min at 50uC followed by 10 min at
25uC, in a solution containing 5.0 mM MgCl2, and 25 mM Na
HEPES pH 7.5. These samples were added to various concen-
trations (0.1 nM, 100 nM, 1.0 mM, 10 mM, 0.1 mM) of an RNA
hexamer (sequence: 59-UUGGGU-39) corresponding to the end of
the 59 exon and necessary for the formation of the P1 helix [20].
Samples were incubated for 10 min at 37uC, added to 50%
glycerol, and loaded on native polyacrylamide gels (6% acrylam-
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The gels were dried and analyzed as described above.
Self-splicing assays
The D.m.[P], B.p.[P] and td[Pm1b] RNAs were tested for self-
splicing activity under a set of conditions previously reported to
efficiently assay self-splicing of group I introns [23]. Self-splicing
reactions proceeded for 1 h or 24 h at various temperatures (see
below) in 10 mL-reaction mixes containing 50 nM RNA (annealed
for 3 min at 50uC, then for 10 min at 32uC in 25 mM Na HEPES
pH 7.5 [38]), 0.1 mM GMP, in one of the following buffers: A,
15 mM MgCl2, 25 mM NaCl, 25 mM Na HEPES pH 7.5
(incubation at 32uC); B, 15 mM MgCl2, 25 mM NaCl, 25 mM
Na HEPES pH 7.5 (incubation at 42uC); C, 15 mM MgCl2,
1.0 M NaCl, 25 mM Na HEPES pH 7.5 (incubation at 32uC); D,
200 mM MgCl2, 25 mM NaCl, 25 mM Na HEPES pH 7.5
(incubation at 32uC); E, 10 mM Mg(OAc)2, 0.4 M NaOAc,
25 mM Na HEPES pH 7.5 (incubation at 32uC). Reactions were
stopped by the addition of a solution containing: 500 mM EDTA;
7.0 M urea; 0.02% bromophenol blue; 0.02% xylene cyanol; 1X
TBE (100 mM Tris-base; 83 mM boric acid; 1.0 mM EDTA).
Products were analyzed by denaturing polyacrylamide gel
electrophoresis (PAGE) as described above.
Crystallization assays
The native-affinity purified C.b. and td variants were diluted to
5–60 mM in a solution containing the following components:
substrate oligonucleotide (1:1.25, RNA:oligonucleotide ratio), 0–
80 mM NaCl or KCl, 10–20 mM MgCl2, 40 mM Na cacodylate
pH 5.5 or pH 6.0. Hanging drops were set up in crystallization
plates by mixing 0.5–1.5 mL of the RNA solution and 0.5–1.5 mL
of a crystallization solution (0.5–1 mL in the well) from the
following screens: Natrix (Hampton Research (HR) #HR2-116);
PEG/Ion Screen (HR #HR2-126); the MPD Suite (Qiagen
#130706); a modified version of the Nucleic Acid Mini-Screen
(HR #HR2-118), containing 2.5–15% MPD in the drop (18–35%
MPD in the well), 1 mM Co
3+ hexamine or 1 mM spermine; a
screen prepared in house, containing as precipitant either 5–30%
1,6-hexanediol, or 5–15% isopropanol, or 1.4–1.8 M (Li)2SO4,o r
1.6–2.2 M (NH4)2SO4, and 2–10 mM Mg(OAc)2, 1 mM sperm-
ine, 2 mM Co
3+ hexamine, 50 mM Na cacodylate pH 6.5. Free
interface diffusion experiments were set up in Topaz chips at the
4.96 format (Fluidigm, www.fluidigm.com) using 1 mL of RNA
solution and 10 mL of crystallization solution per well according to
manufacturer’s instructions. The chips were incubated at 16uC.
X-ray diffraction data collection
The first crystals obtained for the C.b.[Im11] variant were
cryoprotected for 10 min in 60% MPD and flash-frozen in liquid
nitrogen. Data were collected on an R-AXIS IV++instrument with
CuKa X-ray radiation using 1u oscillation angle and 30–45 min
exposures. A 20u wedge of data collected with 45 min exposure
time per frame was reduced using d*TREK (51% completeness).
Additional crystals of the natively-purified and C.b.[Im11]
variant were flash-frozen in liquid nitrogen directly from the
hanging drop, or were first cryoprotected for 5–20 min in various
cryoprotecting solutions (20–60% MPD; 5–20% isopropanol; 10–
20% ethanol; 10–30% MPD together with 10% glycerol or
ethylene glycol). Data were collected at the Howard Hughes
Medical Institute 8.2.1 beamline at the Advance Light Source
(Berkeley, CA), using 0.5u oscillation range and 15 s exposures. A
20u wedge of data was reduced using MOSFLM version 7.0.4 [39]
(41% completeness).
Supporting Information
Table S1 Generic and overlapping primers used in this study.
Found at: doi:10.1371/journal.pone.0006740.s001 (0.03 MB
XLS)
Figure S1 PCR synthesis using overlapping primers. Products
are visualized on agarose gels stained using ethidium bromide.
Expected products are marked by a black triangle. Labels above
each lane indicate the number of overlapping primers (C: control
reactions containing only the generic primers). Labels below each
lane refer to the DNA polymerase used during PCR (T: Taq; P:
Pwo; H: Herculase). A star symbol indicates when 5.0 U instead of
2.5 U Herculase were used. The annealing temperature is shown
in yellow on the top right corner of each gel.
Found at: doi:10.1371/journal.pone.0006740.s002 (2.13 MB TIF)
Figure S2 Purification assays of the C.b.[Im6], C.b.[Im7],
C.b.[Im10], C.b.[Im11] and C.b.[Im12] variants. These variants
were purified using the large-scale purification method (purifica-
tion of 10-mL transcription reaction mixes). The assays were
visualized on 6% denaturing PAGE, and stained using SYBR
Green II. Labels above each lane refer to purification steps
detailed in Figures 1B and 3.
Found at: doi:10.1371/journal.pone.0006740.s003 (0.97 MB TIF)
Figure S3 Purification assays of the A.s.[Pm1] variant at lower
MgCl2 concentration, using CaCl2 in place of MgCl2, and at
pH 6.5–8.0. The results are visualized by denaturing PAGE as in
Figure 3; lanes are labeled according to the purification steps
specified in Figure 1B.
Found at: doi:10.1371/journal.pone.0006740.s004 (4.10 MB TIF)
Figure S4 Self-splicing assays of the D.m.[P] and B.p.[P]
variants. The self-splicing activity was tested under five different
buffer conditions (only three shown; see Methods and [21]).
Found at: doi:10.1371/journal.pone.0006740.s005 (0.33 MB TIF)
Figure S5 Diffraction patterns of C.b.[Im11] variants and
crystalline materials obtained for the C.b.[Im3] and C.b.[Im8]
variants. (A) Diffraction patterns of crystals grown using either the
natively purified RNA (left), or the RNA purified by denaturing
PAGE (right). The 7.0–8.5 angstrom resolution typically obtained
for these crystals is indicated in red. (B) Spherulites (left) and
urchins (right) obtained with the PAGE-purified C.b.[Im3] and
C.b.[Im8] variants, respectively.
Found at: doi:10.1371/journal.pone.0006740.s006 (3.66 MB TIF)
Figure S6 Analysis of the C.b.[Im11] RNA stock after eight
weeks of storage in various conditions. The RNA was in 10 mM
Na cacodylate pH 5.0 in all cases. Approximately 10 pmoles of
RNA were loaded in each lane. The assays were visualized on 6%
denaturing PAGE, and stained using SYBR Green II.
Found at: doi:10.1371/journal.pone.0006740.s007 (0.29 MB TIF)
Figure S7 A two-step PCR strategy to circularly permute the 59
and 39 ends of the C.b. intron into the P6a region. During the first
PCR step, the wild-type C.b. intron (colored from the wild-type 59
end to the P6a helix (red), and from the P6a helix to the wild-type
39 end (brown)) is used as a template for two independent PCR
rounds that contain different sets of primers. During the second
PCR step, the product of each of these reactions is combined to
suitable primers from step #1 in order to amplify the expected
circularly permuted C.b. intron. The incorporated T7 promoter
and restriction sites suitable for cloning are colored as in Figure 1.
Found at: doi:10.1371/journal.pone.0006740.s008 (0.53 MB TIF)
Figure S8 Expression and purification of the TmaM-domain
protein. (A) Cells prior and post-induction with 1.0 mM IPTG (ten
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Supernatent fraction and pellets of three cell lysates. (C) Fraction
of protein eluted from Ni
2+-affinity column and after TEV
cleavage (three fractions were cleaved for 16 h at 25uC by a 1:100
ratio (by mass) of TEV protease, in 10 mM DTT). (D)
Chromatogram after purification of the TmaM-domain on the
SP-Sepharose column (12 fractions were collected, as indicated in
green). The protein eluted around 0.55 M NaCl in 10 mM MES
pH 6.0. (E) Corresponding elution fractions. Fractions #8 and 9
were pooled, dialysed and coupled to the activated support
(Affigel-10; Bio-Rad #153-6046). Gels shown in panels A, B, C,
and E were from SDS-PAGE using 4–12% or 12% acrylamide (as
specified under each gel), and were stained using SimplyBlue
SafeStain (Invitrogen #LC6060); ladders: SeeBlue Plus 2 ((A)–(E);
Invitrogen #LC5925), BenchMark Pre-stained ((E) only; Invitro-
gen #10748-010).
Found at: doi:10.1371/journal.pone.0006740.s009 (3.29 MB
DOC)
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